patient organisations
Patients/ Views & Analysis/ Views and analysis
Education as the solution to the rare disease ‘diagnostic odyssey’
Amanda Barrell
patient groups, patient organisations, scleroderma
0 Comment
Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
BMS launches digital Advocacy Exchange for patient groups affected by COVID-19
George Underwood
BMS, Bristol-Myers Squibb, coronavirus, COVID-19, Digital Health & COVID-19, Gryt Health, patient groups, patient organisations, Pharma’s Digital Response to COVID-19
0 Comment
Industry and patient groups collaborate on new guidance for interaction
George Underwood
comms, IAPO, IFPMA, patient groups, patient organisations
0 Comment
Views & Analysis/ Views and analysis
Why pharma isn’t collaborating with patient organisations as much as it should
George Underwood
Accenture, patient centricity, patient engagement, patient groups, patient organisations
0 Comment
Market Access/ Partner content/ Press releases
Preliminary Attendee List Released for Orphan Drugs & Rare Diseases Conference
Maria Mandic
drug development, orphan drugs, patient centricity, patient organisations, Rare diseases
0 Comment
Attendees Released for Orphan Drugs & Rare Diseases
Partner content/ Press releases/ R&D
How challenges like Brexit & insufficient patients hinder Rare Diseases research
Lyudmyla Durneva
collaboration, Funding, orphan drugs, patient organisations, Rare diseases
0 Comment
Challenges facing Orphan Drugs & Rare Diseases Research